NOBILIS ILT VACCINE

Maa: Australia

Kieli: englanti

Lähde: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktiivinen ainesosa:

INFECTIOUS LARYNGOTRACHEITIS VIRUS (ILT) SERVA STRAIN (L

Saatavilla:

INTERVET AUSTRALIA PTY LIMITED

INN (Kansainvälinen yleisnimi):

vaccine - ILT

Lääkemuoto:

MISC. VACCINES OR ANTI SERA

Koostumus:

INFECTIOUS LARYNGOTRACHEITIS VIRUS (ILT) SERVA STRAIN (L VACCINE-VIRAL Active 0.0 qs dose

Kpl paketissa:

1 to 25 vials; 50 vials

luokka:

VM - Veterinary Medicine

Valmistaja:

INTERVET AUSTRALIA

Terapeuttinen ryhmä:

CHICKEN - OLDER THEN 6 WEEKS

Terapeuttinen alue:

IMMUNOTHERAPY

Käyttöaiheet:

INFECTIOUS LARYNGOTRACHEITIS | GALLID HERPESVIRUS 1 | ILT

Tuoteyhteenveto:

Poison schedule: 0; Withholding period: Zero (0) days. EXPORT SLAUGHTER INTERVA L(ESI): Zero (0) days. Before using this product, confirm the current ESI from I ntervet Australia Pty Ltd on 1800 033 46 1 or the APVMA website (www.apvma.gov.au /residues).; Host/pest details: CHICKEN - OLDER THEN 6 WEEKS: [INFECTIOUS LARYNGOTRACHEITIS]; Poison schedule: 4; Withholding period: Zero (0) days. EXPORT SLAUGHTER INTERVA L(ESI): Zero (0) days. Before using this product, confirm the current ESI from I ntervet Australia Pty Ltd on 1800 033 46 1 or the APVMA website (www.apvma.gov.au /residues).; Host/pest details: CHICKEN - OLDER THEN 6 WEEKS: [INFECTIOUS LARYNGOTRACHEITIS]; Poison schedule: 4; Withholding period: WHP: NIL; Host/pest details: CHICKEN - OLDER THEN 6 WEEKS: [INFECTIOUS LARYNGOTRACHEITIS]; For the protection of chickens older than 6 weeks against infectious laryngotracheitis.This vaccine is NOT BE administered together with other vaccines that have same target organ (respiratory tract). Interval between such vaccinations should be 14 days. Vaccination may cause slight transient conjunctivitis or respiratory reaction in some

Valtuutuksen tilan:

Registered

Valtuutus päivämäärä:

2023-07-01

Pakkausseloste

Product Name:
APVMA Approval No:
NOBILIS ILT VACCINE
59802/130887
Label Name:
NOBILIS ILT VACCINE
Signal Headings:
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
≥ 2.8 log10 EID50 per dose, ILT Virus (living, attenuated). Serva
strain grown on
embryonated eggs.
Claims:
For the protection of chickens older than 6 weeks against Infectious
Laryngotracheitis.
Net Contents:
1 to 25, 50 vials of 1000 Doses, 2000 Doses, 3000 Doses, 4000 Doses,
5000 Doses and
10000 Doses.
Directions for Use:
Restraints:
Contraindications:
Precautions:
Nobilis ILT vaccine should not be administered together with other
vaccines that have the
same target organ (respiratory tract). Interval between such
vaccinations should be 14
days. Vaccination may cause a slight transient conjunctivitis or
respiratory reaction in some
birds.
Side Effects:
Dosage and
Administration:
USE ALL PRODUCT WITHIN 2 HOURS OF RECONSTITUTION.
Vaccination program
It is recommended that susceptible chicken egg layers and chicken
breeders be vaccinated
at 6 weeks and revaccinated at 14-16 weeks of age.
The vaccine may be administered in two ways (Eye drop or Drinking
water).
A) Eye drop RLP APPROVED
Open the vaccine and OCULONASAL diluent vials. Dilute the vaccine with
diluent and
shake gently to fully dissolve the freeze-dried vaccine pellet.
Using the dropper bottle supplied, instil one drop (0.03 mL) of
diluted vaccine into the eye
of the bird. One drop should be applied from a height of a few
centimetres into one eye.
Always hold the dropper bottle inverted in a vertical position to
ensure the correct droplet
size and to avoid loss of vaccine. The presence of a non-toxic blue
dye in the diluent allows
the visual assessment of administration, as the tongue of the bird
will be blue for a short
time after vaccination.
Use plastic gloves when vaccinating.
B) Drinking water
Preparation
1. Check that all drinkers are working properly. Clean drinkers,
header tanks/medication
tanks and medication units - do not use detergent or disinfectant.
2. Calculate doses needed.

Valmisteyhteenveto

PRODUCT NAME:
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY 2014
PAGE: 1 OF 6
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited (trading as MSD Animal
Health) Phone: [phone] (Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Infectious Laryngotracheitis Virus (ILT) Serva strain (living,
attenuated) in an aqueous
suspension with stabilsers and buffering agents.
TRADE NAME:
NOBILIS ILT VACCINE
PRODUCT CODE:
3960
RECOMMENDED USE:
An immunobiological product for use in chickens for vaccination
against Infectious
Laryngotracheitis.
APVMA NO:
59802
THIS VERSION ISSUED:
is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S23, S37, S24/25. Do not breathe mists. Wear suitable gloves. Avoid
contact with skin and eyes.
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Two component system; attenuated virus is a pellet or powder while
diluent is a
clear, colourless liquid.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than mild
transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
SECTION 2 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
POTENTIAL HEALTH EFFECTS
ISSUED BY: INTERVET AUSTRALIA PTY LIMITED
(TRADING AS MSD ANIMAL HEALTH)
91-105 HARPIN STREET
TEL: [phone] (BUSINESS HOURS)
BENDIGO EAST, VIC 3550, AUSTRALIA